Jaguar Animal Health Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$119.31 |
Market Cap |
$173.33 M |
Shares Outstanding |
1.37 M |
Public Float |
20.38 M |
Address |
201 Mission Street San Francisco California 94105 United States |
Employees | - |
Website | http://www.jaguar.health |
Updated | 07/08/2019 |
Jaguar Health, Inc. engages in the dvelopment of gastrointestinal products for both human prescription use and animals. Its products include Mytesi, Canalevia, Equilevia, and Neonorm. The Mytesi product IS use for relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. |